Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism-related genes

The RNA metabolism signature is a prognostic marker that may be useful for predicting survival and optimizing the benefit of adjuvant chemotherapy in patients with lung adenocarcinoma.